CIK 0001641281 · <br>Emerging growth company
Bolt Biotherapeutics, Inc.
Sign in to watch- Ticker
- BOLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472804636
- Phone
- 650-665-9295
- Business address
- 900 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- Bolt Therapeutics, Inc.
- Open-market buys, last 90 days
- $319,000
- in 1 filing
- Open-market sales, last 90 days
- $128,281
- in 3 filings
Net +$190,719. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-24 | HEALY JAMES Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-02-18 | Perez Edith A. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +210,000 | 210,000 | ||
| 2022-02-18 | Yonehiro Grant Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +190,000 | 190,000 | ||
| 2022-02-18 | Quinn William P. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +210,000 | 210,000 | ||
| 2022-02-18 | Dornan David Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +210,000 | 210,000 | ||
| 2022-02-18 | Schatzman Randall C Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +630,000 | 630,000 | ||
| 2021-12-22 | Perez Edith A. Chief Medical Officer | Option exercise | +35,714 | $2.80 | $100K | 37,042 |
| 2021-12-22 | Perez Edith A. Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −35,714 | 189,286 | ||
| 2021-12-14 | ONETTO NICOLE Director | Grant or award · Stock Option (Right to Buy) | +27,860 | 27,860 | ||
| 2021-12-08 | Quinn William P. Chief Financial Officer | Purchase | +5,000 | $4.72 | $24K | 20,154 |
| 2021-12-06 | Perez Edith A. Chief Medical Officer | Purchase | +411 | $4.64 | $2K | 1,328 |
| 2021-12-06 | Quinn William P. Chief Financial Officer | Purchase | +35 | $4.64 | $162 | 15,154 |
| 2021-11-17 | Lee Frank D. Director | Grant or award · Stock Option (Right to Buy) | +27,860 | 27,860 | ||
| 2021-11-17 | O'CALLAGHAN BRIAN Director | Grant or award · Stock Option (Right to Buy) | +27,860 | 27,860 | ||
| 2021-06-04 | Perez Edith A. Chief Medical Officer | Purchase | +917 | $16.65 | $15K | 917 |
| 2021-06-04 | Quinn William P. Chief Financial Officer | Purchase | +1,221 | $16.65 | $20K | 15,119 |
| 2021-02-09 | Novo Holdings A/S 10% owner | Conversion | +4,027,088 | 4,103,991 | ||
| 2021-02-09 | Novo Holdings A/S 10% owner | Purchase | +400,000 | $20.00 | $8.0M | 4,503,991 |
| 2021-02-09 | Novo Holdings A/S 10% owner | Conversion · SERIES A-1 PREFERRED STOCK | −1,096,323 | 0 | ||
| 2021-02-09 | Novo Holdings A/S 10% owner | Conversion · SERIES B PREFERRED STOCK | −2,050,758 | 0 |
Page 13 of 17 · 337 trades